Aura Biosciences Inc (AURA)
NASDAQ:AURA
Want to see AURA full AI Analyst Report?
Total Valuation
Aura Biosciences Inc has a market cap or net worth of $772.30M. The enterprise value is $423.33M.
Market Cap$772.30M
Enterprise Value$423.33M
Share Statistics
Aura Biosciences Inc has 103,386,560 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding103,386,560
Owned by Insiders3.02%
Owned by Institutions33.38%
Financial Efficiency
Aura Biosciences Inc’s return on equity (ROE) is -0.78 and return on invested capital (ROIC) is -73.10%.
Return on Equity (ROE)-0.78
Return on Assets (ROA)-0.63
Return on Invested Capital (ROIC)-73.10%
Return on Capital Employed (ROCE)-0.75
Revenue Per Employee0.00
Profits Per Employee-1.00M
Employee Count106
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Aura Biosciences Inc is ―. Aura Biosciences Inc’s PEG ratio is -5.42.
PE Ratio―
PS Ratio0.00
PB Ratio2.40
Price to Fair Value2.40
Price to FCF-3.86
Price to Operating Cash Flow-5.65
PEG Ratio-5.42
Income Statement
In the last 12 months, Aura Biosciences Inc had revenue of 0.00 and earned -106.19M in profits. Earnings per share was -1.76.
Revenue0.00
Gross Profit0.00
Operating Income-112.79M
Pretax Income-106.08M
Net Income-106.19M
EBITDA-111.66M
Earnings Per Share (EPS)-1.76
Cash Flow
In the last 12 months, operating cash flow was -91.28M and capital expenditures -362.00K, giving a free cash flow of -91.64M billion.
Operating Cash Flow-91.28M
Free Cash Flow-91.64M
Free Cash Flow per Share-0.89
Dividends & Yields
Aura Biosciences Inc pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.60
52-Week Price Change28.79%
50-Day Moving Average7.11
200-Day Moving Average6.23
Relative Strength Index (RSI)52.24
Average Volume (3m)637.51K
Important Dates
Aura Biosciences Inc upcoming earnings date is Aug 6, 2026, After Close (Confirmed).
Last Earnings DateMay 11, 2026
Next Earnings DateAug 6, 2026
Ex-Dividend Date―
Financial Position
Aura Biosciences Inc as a current ratio of 8.15, with Debt / Equity ratio of 15.84%
Current Ratio8.15
Quick Ratio8.15
Debt to Market Cap0.05
Net Debt to EBITDA0.38
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Aura Biosciences Inc has paid 108.00K in taxes.
Income Tax108.00K
Effective Tax Rate>-0.01
Enterprise Valuation
Aura Biosciences Inc EV to EBITDA ratio is -2.57, with an EV/FCF ratio of -3.37.
EV to Sales0.00
EV to EBITDA-2.57
EV to Free Cash Flow-3.37
EV to Operating Cash Flow-3.38
Balance Sheet
Aura Biosciences Inc has $114.73M in cash and marketable securities with $16.99M in debt, giving a net cash position of $97.74M billion.
Cash & Marketable Securities$114.73M
Total Debt$16.99M
Net Cash$97.74M
Net Cash Per Share$0.95
Tangible Book Value Per Share$2.27
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Aura Biosciences Inc is $19.75, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$19.75
Price Target Upside170.92% Upside
Analyst ConsensusStrong Buy
Analyst Count5
Revenue Growth Forecast―
EPS Growth Forecast7.21%